Jump to main content
Jump to site search

Issue 9, 2018
Previous Article Next Article

Link between a high kon for drug binding and a fast clinical action: to be or not to be?

Author affiliations

Abstract

Review articles on binding kinetics essentially focus on drugs that dissociate slowly from their target since this is required for the successful treatment of many pathophysiological conditions. Recently, the therapeutic benefit of a high kon (i.e. the second order association rate constant) has also been linked to fast association and to a fast clinical action. Other studies, however, called this assertion into question since additional factors, like the dosing paradigm and the binding mechanism, are important as well. The still ongoing reticence about integrating binding kinetics in lead optimization programs motivated us to critically review the link between the drug's kinetic rate constants and their in vitro and in vivo target occupancy profile, with special focus on kon. The presented simulations tally with a positive link between a drug's effective/observed association rate (which is quite easy to determine in vitro) and the swiftness of its clinical action. On the other hand, the simulations show that the kon-concept should not be confounded with the effective association process since increasing this parameter only enhances the drug's in vitro and in vivo association under certain conditions: the binding mechanism should be suitable, rebinding (and thus the factors within the target's micro-environment that favour this mechanism) should not be too prominent and the dosage should not be kept in par with the drug's affinity. Otherwise, increasing kon could be ineffective or even be counter-productive.

Graphical abstract: Link between a high kon for drug binding and a fast clinical action: to be or not to be?

Back to tab navigation

Supplementary files

Publication details

The article was received on 11 Jun 2018, accepted on 15 Aug 2018 and first published on 16 Aug 2018


Article type: Review Article
DOI: 10.1039/C8MD00296G
Citation: Med. Chem. Commun., 2018,9, 1426-1438
  •   Request permissions

    Link between a high kon for drug binding and a fast clinical action: to be or not to be?

    G. Vauquelin, Med. Chem. Commun., 2018, 9, 1426
    DOI: 10.1039/C8MD00296G

Search articles by author

Spotlight

Advertisements